Product NDC: | 0409-6476 |
Proprietary Name: | Erythrocin Lactobionate |
Non Proprietary Name: | ERYTHROMYCIN LACTOBIONATE |
Active Ingredient(s): | 500 mg/100mL & nbsp; ERYTHROMYCIN LACTOBIONATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-6476 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062638 |
Marketing Category: | ANDA |
Start Marketing Date: | 19861031 |
Package NDC: | 0409-6476-44 |
Package Description: | 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-6476-44) > 100 mL in 1 VIAL, PATENT DELIVERY SYSTEM |
NDC Code | 0409-6476-44 |
Proprietary Name | Erythrocin Lactobionate |
Package Description | 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-6476-44) > 100 mL in 1 VIAL, PATENT DELIVERY SYSTEM |
Product NDC | 0409-6476 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ERYTHROMYCIN LACTOBIONATE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19861031 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | ERYTHROMYCIN LACTOBIONATE |
Strength Number | 500 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |